Cargando…
Corrigendum: Low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: A systematic review and meta-analysis
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686818/ https://www.ncbi.nlm.nih.gov/pubmed/36439122 http://dx.doi.org/10.3389/fimmu.2022.1052766 |
_version_ | 1784835848057913344 |
---|---|
author | Xia, Hui Wang, Ziyao Tian, Min Liu, Zunjing Zhou, Zhenhua |
author_facet | Xia, Hui Wang, Ziyao Tian, Min Liu, Zunjing Zhou, Zhenhua |
author_sort | Xia, Hui |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9686818 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96868182022-11-25 Corrigendum: Low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: A systematic review and meta-analysis Xia, Hui Wang, Ziyao Tian, Min Liu, Zunjing Zhou, Zhenhua Front Immunol Immunology Frontiers Media S.A. 2022-11-10 /pmc/articles/PMC9686818/ /pubmed/36439122 http://dx.doi.org/10.3389/fimmu.2022.1052766 Text en Copyright © 2022 Xia, Wang, Tian, Liu and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Xia, Hui Wang, Ziyao Tian, Min Liu, Zunjing Zhou, Zhenhua Corrigendum: Low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: A systematic review and meta-analysis |
title | Corrigendum: Low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: A systematic review and meta-analysis |
title_full | Corrigendum: Low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: A systematic review and meta-analysis |
title_fullStr | Corrigendum: Low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: A systematic review and meta-analysis |
title_full_unstemmed | Corrigendum: Low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: A systematic review and meta-analysis |
title_short | Corrigendum: Low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: A systematic review and meta-analysis |
title_sort | corrigendum: low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: a systematic review and meta-analysis |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686818/ https://www.ncbi.nlm.nih.gov/pubmed/36439122 http://dx.doi.org/10.3389/fimmu.2022.1052766 |
work_keys_str_mv | AT xiahui corrigendumlowmolecularweightheparinversusaspirininearlymanagementofacuteischemicstrokeasystematicreviewandmetaanalysis AT wangziyao corrigendumlowmolecularweightheparinversusaspirininearlymanagementofacuteischemicstrokeasystematicreviewandmetaanalysis AT tianmin corrigendumlowmolecularweightheparinversusaspirininearlymanagementofacuteischemicstrokeasystematicreviewandmetaanalysis AT liuzunjing corrigendumlowmolecularweightheparinversusaspirininearlymanagementofacuteischemicstrokeasystematicreviewandmetaanalysis AT zhouzhenhua corrigendumlowmolecularweightheparinversusaspirininearlymanagementofacuteischemicstrokeasystematicreviewandmetaanalysis |